About

World-Leading Research

Accelerator supports the commercialisation of health and life science research and allows knowledge transfer between business leaders, clinical colleagues, key opinion leaders and academics.

The Accelerator is co-located to the National Institute for Health Research (NIHR) MHRA Phase 1 Accredited Clinical Research Facility that is based in the Royal Liverpool Hospital and the University of Liverpool Bio Banks, allowing companies further opportunities for research and development. This focus and concentration of research activity covers all aspects of medical and life sciences research and draws in expertise from additional disciplines such as engineering, chemistry and computer science to develop the next generation of therapies, diagnostics, medical devices and care practices that are transforming human healthcare in the 21st Century. Accelerator brings you into these networks through our organised events and informal contacts.

Standing at the heart of the Knowledge Quarter Liverpool, Accelerator has a core role in encapsulating these resources and offering these opportunities to inventors, enterprises and entrepreneurs.

View the Accelerator Brochure

(PDF. Opens in new window)

Accelerator Building

Standing at the heart of the KQ Liverpool, Accelerator provides opportunities to inventors, enterprises and entrepreneurs.

The Royal Liverpool & Broadgreen University Hospitals NHS Trust is one of the largest university teaching hospitals in the North West of England. It is comprised of the Royal Liverpool University Hospital, the Liverpool University Dental Hospital and Broadgreen Hospital.

As a centre of excellence for research, development and innovation, the Trust has long standing partnerships with the University of Liverpool, Liverpool John Moores University and the Liverpool School of Tropical Medicine.

The Trust incorporates a Biomedical Research Unit which is the only one of its kind nationally focusing on pancreatic disease and a research centre for infectious and microbial disease which works closely with the world-renowned Liverpool School of Tropical Medicine. Together with the Cancer Research UK accredited Cancer Research Centre and the Clinical Research Facilities, these have enabled the Trust to develop depth and breadth in research activities.

The Trust offers high quality treatment and diagnosis across more than twenty specialties and hosts several nationally and internationally regarded services, many with leading edge research. These include ophthalmology, pancreatic surgery, gastroenterology, pathology, vascular surgery and interventional radiology. The Trust also provides regional services in nephrology and renal transplantation, nuclear medicine, haematology, dermatology, urology and dental.

The Trust is a major provider of cancer services and is the regional centre for pancreatic, urology, haematology, ocular oncology, testicular, anal, oesophago-gastric, specialist palliative care, specialist radiology and specialist pathology. In addition the Trust offers excellent local cancer treatment services.

For more info, please visit: www.rlbuht.nhs.uk

For more info, please visit: www.clinicalresearchliverpool.nihr.ac.uk

The Liverpool School of Tropical Medicine (LSTM) was the first institution in the world dedicated to research and teaching in tropical medicine. Sir Ronald Ross, Professor of Tropical Medicine at LSTM, became the first British winner of a Nobel Prize for medicine when, in 1902, he was recognised for his discovery that malaria is carried by mosquitoes. LSTM now trains over 500 students a year from more than seventy countries and holds research contracts to the value of £159m. Over the last ten years, annual turnover has increased from £7m to more than £50m and staff numbers have nearly doubled to some 300 people.

LSTM has a strong, internationally excellent research profile with notable strengths in entomological research and drug development. The World Health Organization (WHO), in consultation with the UK government, recently designated LSTM as a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases. Attracting world-class researchers, scientists and professors, LSTM is an important bioscience asset which significantly contributes to the city region’s knowledge economy.

The new Centre for Tropical and Infectious Diseases (CTID) has considerably expanded research facilities and greatly increased capacity to research and develop new drugs, vaccines and pesticides to combat some of the world’s most devastating diseases. Translational research accounts for an increasing proportion of overall output, bringing research innovation and scientific breakthroughs from the lab to those most in need in the form of new drugs, vaccines, improved vector control products and improved diagnostics and information systems.

For more info, please visit: www.lstmed.ac.uk

Starting or growing a life science business?

Contact the Accelerator team now to see how we can help you speed up your growth.